Essa Pharma Inc Expected To Post A Loss Of 19 Cents A Share: Earnings Preview

ESSA Pharma

03/05/2024 14:22

* ESSA Pharma Inc  EPIX.OQ   EPIX.O  is expected to show no
change
in quarterly revenue when it reports  results on May 7
(estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for ESSA Pharma Inc is for a
loss
of 19 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ESSA Pharma
Inc
is $17.00​, above​ its last closing price of $6.95. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.17       -0.17      -0.14     Beat    18.8
 Sep. 30 2023              -0.21      -0.12     Beat    42.9
 Jun. 30 2023  -0.19       -0.19      -0.17     Beat    12.8​
 Mar. 31 2023  -0.20       -0.20      -0.16     Beat    22
 ​​Dec.        -0.22       -0.23      -0.15     Beat    36.2
 31 2022                                                
 Sep. 30 2022              -0.27      -0.14     Beat    49.1​
 Jun. 30 2022  -0.28       -0.27      -0.20     Beat    25.9
 Mar. 31 2022  -0.26       -0.25      -0.25     Met     1
 This summary was machine generated May 3 at 13:22 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)